ArticleJournal of immunology research2022

Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment.

Anqi Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.